Drug firm Wockhardt on Thursday reported over two-fold increase in consolidated net profit at Rs 428 crore (Rs 4.28 billion) for the third quarter ended December 31, on robust sales across international markets, including US.
The company had posted a net profit of Rs 213 crore (Rs 2.13 billion) in the same period of previous fiscal.
Consolidated net sales of the company rose to Rs 1,435 crore (Rs 14.35 billion) in the third quarter from to Rs 1,141 crore (Rs 11.41 billion) in the corresponding 2011-12 fiscal, Wockhardt Ltd said in a statement.
The Mumbai-based firm said its international business contributed 83
per cent of the total revenues during the quarter.
"Wockhardt's US business recorded a growth of 45 per cent compared to the corresponding quarter of 2011-12 fiscal," it said.
During the period under review, the company said its UK business recorded a growth of 19 per cent compared to the corresponding quarter of previous fiscal.
The company's India business grew by 14 per cent and the emerging markets business grew by 18 per cent compared to the corresponding quarter of 2011-12 fiscal, it said.
Shares of Wockhardt on Thursday closed at Rs 1,728.75 on the Bombay Stock Exchange, down 2.12 per cent from their previous close.
